# A Phase 1 Study of BST02 in Treating Locally Advanced Liver Cancer

> **NCT06526832** · PHASE1 · UNKNOWN · sponsor: **BioSyngen Pte Ltd** · enrollment: 9 (estimated)

## Conditions studied

- Locally Advanced Liver Carcinoma

## Interventions

- **BIOLOGICAL:** BST02

## Key facts

- **NCT ID:** NCT06526832
- **Lead sponsor:** BioSyngen Pte Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-07-04
- **Primary completion:** 2025-07-03
- **Final completion:** 2025-12-03
- **Target enrollment:** 9 (ESTIMATED)
- **Last updated:** 2024-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06526832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06526832, "A Phase 1 Study of BST02 in Treating Locally Advanced Liver Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06526832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*